28-3500
Sodium nitroferricyanide(III) dihydrate
JIS special grade, ≥99.0%
Sinónimos:
Nitroprusside sodium, SNP, Sodium nitroprusside, Sodium pentacyanonitrosylferrate
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
Na2[Fe(CN)5NO] · 2H2O
Número CAS:
Peso molecular:
297.95
UNSPSC Code:
12352300
PubChem Substance ID:
EC Number:
238-373-9
MDL number:
Assay:
≥99.0%
Grade:
JIS special grade
Form:
solid
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarlegrade
JIS special grade
assay
≥99.0%
form
solid
reaction suitability
reagent type: catalyst
core: iron
availability
available only in Japan
SMILES string
[Na+].[Na+].[H]O[H].[H]O[H].O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N
InChI
1S/5CN.Fe.NO.2Na.2H2O/c5*1-2;;1-2;;;;/h;;;;;;;;;2*1H2/q;;;;;2*-1;2*+1;;
InChI key
OIRZWVYIQXBRFC-UHFFFAOYSA-N
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
Clase de almacenamiento
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Galen W Heyne et al.
Investigative ophthalmology & visual science, 54(7), 5103-5110 (2013-06-27)
To determine the effect of the nitric oxide donor, sodium nitroprusside (SNP), and the nitric oxide synthase (NOS) inhibitor, L-nitro-arginine-methylester (L-NAME), on IOP, mean arterial pressure (MAP), pupil diameter (PD), refraction (Rfx), aqueous humor formation (AHF), and outflow facility (OF)
Song Guo et al.
Cephalalgia : an international journal of headache, 33(5), 301-307 (2013-02-14)
Sodium nitroprusside (SNP) is a powerful vasodilatory agent that, similarly to glyceryl trinitrate (GTN), releases nitric oxide (NO) but in contrast does not pass the blood-brain barrier. Nevertheless, it has already been used in animal models without any knowledge of
Mackram F Eleid et al.
Circulation, 128(12), 1349-1353 (2013-08-21)
Low-gradient severe aortic stenosis with preserved ejection fraction is an increasingly recognized entity, and symptomatic patients may benefit from aortic valve replacement. However, systemic hypertension frequently coexists with low-gradient severe aortic stenosis, which itself may cause elevated left ventricular (LV)